Yemeni company develops anti-viral drug for H1N1 flue

SANA'A, Oct.08(Saba) - The
Yemeni pharmaceutical company YEDCO has developed anti-viral drug for the Swine Flue
(H1N1)
and registered it at the Yemeni General Authority of Medicines and Medical Supplements.
General Director of the High Authority for Medicines and Medical Supplements Dr.
Abdul-Monem al-Hakami said that the drug registered by YEDCO at the authority is
the same
medicine invented by a Switzerland company before years.
Speaking to Saba, al-Hakami added that the Switzerland medicine called "Tamiflu",
which consists of Oseltaamivir phosphate75mg capsules, is anti-viral drug for the
seasonal
flue that approved recently by WHO as anti-viral drug for curing Swine Flue and Bird
Flue and now being produced by a number of companies in the world.
YEDCO's General Manager Mohammed Abdul-Kader made it clear that the Yemeni company
developed the Switzerland medicine after getting a license from another company
which
is licensed by the mother company.
He pointed that a Yemeni specialized medical team has developed the drug after
conducting a number of medical studies and tests in the company according to the
global medical
standards, noting that YEDCO is the first local company develops and registers this
medicine.
After two years from the scientific studies and tests on the medicine used for
curing Bird flue, which was developed to be used as anti-viral for H1N1virus ,
indicating
that the new medicine which called "Aviflu" is now available in a number of the
local pharmacies and hospitals, Abdul-Kader Added.
BA